Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
1,034.00
Year-over-Year Change
-3.63%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks short-term bank loans for pharmaceutical and medicine corporations in the United States. It provides insight into the sector's short-term financial borrowing and liquidity strategies.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The metric represents the total value of bank loans with an original maturity of one year or less for U.S. pharmaceutical companies. Economists use this data to assess the financial health, credit access, and working capital needs of the pharmaceutical industry.
Methodology
Data is collected through quarterly financial reports submitted by corporations to regulatory agencies and compiled by the Federal Reserve.
Historical Context
This trend is used to analyze industry credit conditions, assess corporate financial strategies, and understand sectoral financial dynamics.
Key Facts
- Measures short-term bank loans for pharmaceutical corporations
- Reflects industry's working capital and liquidity strategies
- Provides quarterly snapshot of sector's financial borrowing
FAQs
Q: What does this trend indicate about pharmaceutical companies?
A: It shows how much short-term bank financing pharmaceutical companies are accessing. This can reflect their current financial health and credit needs.
Q: Why are short-term loans important for pharmaceutical firms?
A: Short-term loans help companies manage cash flow, fund research, cover operational expenses, and maintain financial flexibility.
Q: How often is this data updated?
A: The data is typically updated quarterly, providing a current view of the pharmaceutical sector's financial borrowing patterns.
Q: How do economists use this trend?
A: Economists analyze this trend to understand industry credit conditions, assess financial strategies, and gauge the overall economic health of the pharmaceutical sector.
Q: What limitations exist in this data?
A: The trend only captures bank loans and does not include other forms of financing like bonds, equity, or private investments.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Wood Products: Interest Expense
QFR105321USNO
Quarterly Financial Report: U.S. Corporations: All Wholesale Trade: Retained Earnings
QFR322WHSUSNO
Quarterly Financial Report: U.S. Corporations: All Other Chemicals: Cash Dividends Charged to Retained Earnings This Quarter
QFR120325USNO
Chicago Fed National Financial Conditions Index Nonfinancial Leveral Subindex
NFCINONFINLEVERAGE
Quarterly Financial Report: U.S. Corporations: All Durable Manufacturing: Cash Dividends Charged to Retained Earnings This Quarter
QFR120DURUSNO
Quarterly Financial Report: U.S. Corporations: All Durable Manufacturing: Total Assets
QFR223DURUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks [QFR301385USNO], retrieved from FRED.
Last Checked: 8/1/2025